| abstract |
The present invention relates to novel vaccines, uses for immunoprophylaxis and treatment of Candida mycosis in human medicine and veterinary medicine, and a method for producing the same: The vaccine of the present invention is Candida strain a1) Candida albicans ) CCM 8355, a2) Candida glabrata CCM 8356, a3) Candida krusei CCM 8357 and a4) an immunoregulatory Propionibacterium acnes strain and optionally a combination of pharmaceutically acceptable auxiliaries such as carriers, The ratio a1: a2: a3: a4 of the components a1-a4 in the final product is 10-20: 10-20: 10-20: 40-70. |